A clinical perspective from Dr. Siddharth Sheth
See how Signatera™ MRD testing flagged HNSCC recurrence before CT imaging, providing a lead-time advantage that can inform treatment.
Watch Video
Oncology
Resources related to tests that help detect circulating tumor DNA for molecular residual disease assessment.
-
-
Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases
Kataoka, K, et al. JAMA Oncology, 2026
Read More
-
Redefining HNSCC Management with Signatera™ MRD Testing: A Multidisciplinary Perspective
Watch Video
-
My patient is Signatera-positive. Now What?
Watch Video
-
Molecular Residual Disease (MRD) Testing: Advancing Clinical Decision-Making in Breast Cancer
Read More
-
MRD Insights for Radiation Oncology in NSCLC
Watch Video
-
Latitude One Pager
Read More
-
Anal One Pager
Read More
-
HCC One Pager
Read More
-
MDT+TOMR One Pager
Read More
-
Gastroesophageal One Pager
Read More
-
Pancreas One Pager
Read More
-
From Clinical Insight to Trial Design: Advancing Circulating Tumor DNA-Informed Care in Pancreatic Cancer
Ascherman B, King D. J Gastrointest Oncol 2026
Read More
-
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer a randomized phase 3 trial
Bando et al. Nature, 2026
Read More
-
ASBrS 2026: Optimizing Breast Cancer
Leading Breast Surgeons Discuss MRD Testing
Watch Video
-
When Sample Type Matters: The Utilization of Fibroblast Testing in Hereditary Cancer
Watch Video
-
Cell Culturing for Skin Fibroblast Testing Requisition Form
Read More
-
Fibroblast Ordering Guide
Read More
-
Fibroblast Brochure
Read More
-
Altera™ Brochure
Read More
-
Loading More...
